20947. ANÁLISIS DEL TAMAÑO DEL EFECTO DE CIPAGLUCOSIDASA ALFA MÁS MIGLUSTAT FRENTE A ALGLUCOSIDASA-ALFA EN ADULTOS CON ENFERMEDAD DE POMPE DE INICIO TARDÍO PRETRATADOS CON TERAPIA DE SUSTITUCIÓN ENZIMÁTICA
Saved in:
| Main Authors: | A. Aguinaga-Barrilero, J. Alonso Pérez, D. Bratkovic, B. Byrne, K. Claeys, P. Clemens, J. Díaz Manera, M. Dimachkie, P. Kishnani, H. Kushlaf, M. Roberts, A. Toscano, J. Castelli, F. Holdbrook, S. Sitaraman Das, T. Mozaffar, B. Schoser |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Neurology Perspectives |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667049624008287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2024-10-01) -
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2025-01-01) -
Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
by: Elizabeth K. Baker, et al.
Published: (2025-01-01) -
20590. RT-QUIC DE ALFA-SINUCLEÍNA Y COPATOLOGÍA ALZHEIMER EN PACIENTES CON DEMENCIA CON CUERPOS DE LEWY
by: E. Puiggròs Rubiol, et al.
Published: (2024-11-01) -
Estilos de vida da “Geração Alfa”
by: Paula Vianna Köche
Published: (2024-12-01)